Logo BaseClick

The Click Chemistry Platform

Interesting Life Sciences News

09th July 2019
Milestone for BioNTech: 325 Million USD for further development of its cancer immunotherapy.


22nd April 2019

Eli Lilly and Avidity Biosciences announce licensing & research cooperation on combined monoclonal antibodies and oligonucleotide-based therapies for potential new medicines in immunology and other select indications.

01st November 2018
llumina acquires Pacific Biosciences for approximately $1.2 Billion


 

Our Mission, Technology & Key Products

As leading pioneer in high-end nucleic acid modification & conjugation, we understand ourselves as transformative enabler for the development of new and value added applications, e.g. single-molecule NGS sequencing, best-in-class cell proliferation tests, engineered mRNA,…

Based on our perfected bioconjugation concept, we offer ready-to-use clickable products, custom oligos as well as our powerful technology next to product development services.